Research collaboration
& partnering
Early-stage partnering with companies
| 2024 | License agreement for a pre-clinical asset（Japanese biotech company） |
|---|---|
| 2022 | License agreement for a pre-clinical asset（Japanese biotech company） |
| 2020 | License agreement for a pre-clinical asset（Japanese bio-venture firm） |
| 2019 | Research collaboration for drug discovery（Japanese startup） |
| 2018 | Research collaboration for drug discovery（Japanese IT company） |
| 2016 | Global strategic alliance（Finnish pharmaceutical company） |
| 2016 | License agreement for a pre-clinical asset（US biopharmaceutical company） |
| 2016 | Joint R&D agreement for drug discovery（Japanese biopharmaceutical company） |
| 2014 | Research collaboration for drug discovery（Japanese bio-venture firm） |
| 2013 | Research collaboration for drug（England pharmaceutical company） |
Please visit and find our partnering activities at all stage.
https://www.asahi-kasei.co.jp/pharma/en/partnering/
https://www.asahi-kasei.co.jp/pharma/en/partnering/
Research collaboration with academia
